BradleyRobertCorrMD

Obstetrics & Gynecology • Aurora, CO

Gynecologic Oncology

Assistant Professor - Division of Gynecologic Oncology at University of Colorado Anschutz Medical Campus

Join to view full profile

Dr. Corr is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Corr's full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

University of ColoradoFellowship, Gynecologic Oncology, 2013 - 2016
University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 2009 - 2013
Vanderbilt University School of MedicineClass of 2009
Middlebury CollegeBA, 1998 - 2002

Certifications & Licensure

CO State Medical License 2013 - 2025
PA State Medical License 2009 - 2013
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer Start of enrollment: 2009 Nov 03
Active, not recruiting
Phase 1, Phase 2
Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors Start of enrollment: 2012 May 01
Completed
Phase 1
Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer Start of enrollment: 2017 Mar 10
Completed
Phase 2
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer Start of enrollment: 2016 Dec 01
Completed
Phase 1
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors Start of enrollment: 2018 May 30
Active, not recruiting
Phase 1
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer Start of enrollment: 2017 Jun 14
Terminated
Phase 2
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer Start of enrollment: 2017 Sep 28
Terminated
Phase 2
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer Start of enrollment: 2021 Nov 29
Recruiting
Phase 2
Roles: Contact, Principal Investigator
First in Human Study of IMGN151 in Recurrent Endometrial Cancer and Recurrent, High-grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Start of enrollment: 2023 Jan 11
Recruiting
Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer.
Alessandro D Santin, Bradley R Corr, Alexander Spira, Lyndsay Willmott, James Butrynski
Journal of Clinical Oncology. 2024-10-10
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research.
Laura Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel Spakowicz
Clinical Cancer Research. 2024-07-15
1 citations
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study.
Antonio González-Martín, Hyun Cheol Chung, Esma Saada-Bouzid, Eduardo Yanez, Helene Senellart
Gynecologic Oncology. 2024-07-01

Journal Articles

Minority Race Predicts Treatment by Non-Gynecologic Oncologists in Women with Gynecologic Cancer
Saketh R Guntupalli, Amin A Ramzan, Kian Behbakht, Bradley R Corr, Annals of Surgical Oncology

Lectures

Survival and clinical outcomes of ovarian cancer patients enrolled in phase I clinical trials.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Ovarian Cancer Experts Gather on the CU Anschutz Campus for Third Annual Think Tank EventOctober 22nd, 2024
R37 MERIT Award Supports Innovative Ovarian Cancer ResearchSeptember 18th, 2021
Living to Live: Friends Face off Cancer; Find Strength in Each OtherSeptember 15th, 2020
Join now to see all

Committees

Core member, NRG Rare Tumor Committee 2017 - Present

Professional Memberships

American College of Obstetricians and Gynecologists
Member
American Society of Clinical Oncology - ASCO
Member
Society of Gynecologic Oncology (SGO)
Member
Western Association of Gynecologic Oncologists (WAGO)
Member